Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With "No Evidence of Disease" After Complete Surgical Resection of "Locally Advanced" and/or Stage IV Melanoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01989572
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:39.835823+00:00
Published At
2014-08-12T00:00:00+00:00
Record Updated At
2020-07-07
Results Posted At
2014-08-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Iris Melanoma", "Medium/Large Size Posterior Uveal Melanoma", "Mucosal Melanoma", "Ocular Melanoma With Extraocular Extension", "Recurrent Melanoma", "Recurrent Uveal Melanoma", "Small Size Posterior Uveal Melanoma", "Stage IIA Cutaneous Melanoma AJCC v6 and v7", "Stage IIA Uveal Melanoma AJCC v7", "Stage IIB Cutaneous Melanoma AJCC v6 and v7", "Stage IIB Uveal Melanoma AJCC v7", "Stage IIC Cutaneous Melanoma AJCC v6 and v7", "Stage IIIA Cutaneous Melanoma AJCC v7", "Stage IIIA Uveal Melanoma AJCC v7", "Stage IIIB Cutaneous Melanoma AJCC v7", "Stage IIIB Uveal Melanoma AJCC v7", "Stage IIIC Cutaneous Melanoma AJCC v7", "Stage IIIC Uveal Melanoma AJCC v7", "Stage IV Cutaneous Melanoma AJCC v6 and v7", "Stage IV Uveal Melanoma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-07-07"
protocolSection.identificationModule.nctId
"NCT01989572"
protocolSection.identificationModule.officialTitle
"A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With \"No Evidence of Disease\" After Complete Surgical Resection of \"Locally Advanced\" and/or Stage IV Melanoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-08-12"

Study condition terms

  • Iris Melanoma (protocolSection.conditionsModule.conditions)
  • Medium/Large Size Posterior Uveal Melanoma (protocolSection.conditionsModule.conditions)
  • Mucosal Melanoma (protocolSection.conditionsModule.conditions)
  • Ocular Melanoma With Extraocular Extension (protocolSection.conditionsModule.conditions)
  • Recurrent Melanoma (protocolSection.conditionsModule.conditions)
  • Recurrent Uveal Melanoma (protocolSection.conditionsModule.conditions)
  • Small Size Posterior Uveal Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIA Cutaneous Melanoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIA Uveal Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIB Cutaneous Melanoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIB Uveal Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIC Cutaneous Melanoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Uveal Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Uveal Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Uveal Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Cutaneous Melanoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Uveal Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.